Ethnic differences in effects of opioid blockade and behavioral analgesia on pain

阿片类药物阻断和行为镇痛对疼痛影响的种族差异

基本信息

  • 批准号:
    7644392
  • 负责人:
  • 金额:
    $ 4.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-16 至 2010-08-15
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Persistent pain is a public health epidemic producing enormous economic costs and profound human suffering. Considerable evidence indicates that, compared to non-Hispanic whites, African Americans are at substantially higher risk for experiencing severe, disabling, clinical pain states (both acute and chronic), and are more sensitive to a broad variety of noxious stimuli delivered in laboratory studies. While major advances in many areas of pain research have been made in recent years, explanations for the ethnic differences observed in responses to pain remain poorly understood. In light of the increasing diversity of the US population, illuminating the mechanisms that underlie ethnic differences in pain perception has become a topic of substantial scientific and clinical importance, and extending this line of research should eventually aid in reducing pain-related disparities in health. Therefore, the purpose of this proposal is to elucidate the role of the endogenous opioid system in contributing to ethnic differences in the experience of pain. Specifically, this project will investigate responses to capsaicin-induced pain, the analgesic effects produced by a cognitive-behavioral pain-coping strategy (i.e., distraction), and whether blockade of the endogenous opioid system affects ethnic differences in pain and analgesia in a sample of 52 medically healthy individuals (50% African American, 50% non-Hispanic White; 50% Women in each ethnic group). The aims of the current proposal are to: 1) evaluate ethnic differences in the contribution of endogenous opioids in pain perception of capsaicin induced pain; 2) characterize differences in the effectiveness of distraction analgesia during capsaicin-induced pain among African Americans and non-Hispanic whites; 3) determine whether ethnic differences in the effectiveness of a distraction analgesia task are influenced by endogenous opioids; and 4) whether psychological factors influence ethnic differences in pain sensitivity, response to the behavioral analgesic manipulation (distraction), or opioid receptor blockade. Subjects will participate in four experimental sessions (in a randomized order); in each of these they will be exposed to capsaicin "alone" or during a distraction task, and will undergo double-blinded administration of either naloxone, an opioid antagonist, or saline. Collectively, the findings from this proposed study will provide valuable insight into the mechanisms underlying ethnic differences in pain perception, and will provide the most definitive answer to date regarding the contribution of endogenous opioids to ethnic differences in pain, Identifying the neurobiological pathways that contribute to ethnic differences in the experience of pain will eventually provide targets for intervention to reduce the scope and impact of pain among African-Americans.
描述(申请人提供):持续性疼痛是一种公共卫生流行病,会产生巨大的经济成本和深刻的人类痛苦。大量证据表明,与非西班牙裔白人相比,非裔美国人经历严重、致残、临床疼痛状态(包括急性和慢性)的风险要高得多,而且对实验室研究中提供的各种有害刺激更敏感。虽然近年来在疼痛研究的许多领域取得了重大进展,但对疼痛反应中观察到的种族差异的解释仍然很少。鉴于美国人口的日益多样化,阐明疼痛感知的种族差异背后的机制已成为一个具有重大科学和临床重要性的话题,扩展这一研究路线最终将有助于缩小与疼痛相关的健康差异。因此,这项建议的目的是阐明内源性阿片系统在疼痛体验中的种族差异中所起的作用。具体地说,这个项目将调查对辣椒素诱导的疼痛的反应,认知-行为疼痛应对策略(即分心)产生的止痛效果,以及阻断内源性阿片系统是否会影响52名医学健康个体(非洲裔美国人50%,非西班牙裔白人50%,每个种族女性50%)在疼痛和止痛方面的种族差异。当前建议的目的是:1)评估内源性阿片类药物在辣椒素诱导的疼痛感知中的贡献的种族差异;2)表征非裔美国人和非西班牙裔白人在辣椒素诱导的疼痛期间牵张止痛有效性的差异;3)确定分心止痛任务的有效性的种族差异是否受到内源性阿片类药物的影响;以及4)心理因素是否影响疼痛敏感性、对行为止痛操作(分心)或阿片受体阻断的反应的种族差异。受试者将参加四次实验(以随机顺序);在每一次实验中,他们都将单独或在分心任务中接触辣椒素,并将接受纳洛酮、阿片类拮抗剂或生理盐水的双盲给药。总之,这项拟议研究的结果将为疼痛感知的种族差异提供有价值的见解,并将提供迄今为止关于内源性阿片类药物对疼痛种族差异的贡献的最明确答案,确定导致疼痛体验种族差异的神经生物学途径,最终将提供干预目标,以减少非裔美国人疼痛的范围和影响。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pain catastrophizing may moderate the association between pain and secondary hyperalgesia.
  • DOI:
    10.1111/jabr.12096
  • 发表时间:
    2017-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Pressman;B. Peterlin;D. Tompkins;R. Salas;L. Buenaver;J. Haythornthwaite;C. Campbell
  • 通讯作者:
    A. Pressman;B. Peterlin;D. Tompkins;R. Salas;L. Buenaver;J. Haythornthwaite;C. Campbell
Ethnic Differences in Experimental Pain Responses Following a Paired Verbal Suggestion With Saline Infusion: A Quasiexperimental Study.
配对口头建议与盐水输注后实验性疼痛反应的种族差异:一项准实验研究。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Claudia Michelle Campbell其他文献

Claudia Michelle Campbell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Claudia Michelle Campbell', 18)}}的其他基金

Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis
中枢敏化和睡眠障碍作为膝骨关节炎患者治疗结果的预测因素
  • 批准号:
    10456895
  • 财政年份:
    2021
  • 资助金额:
    $ 4.82万
  • 项目类别:
Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis
中枢敏化和睡眠障碍作为膝骨关节炎患者治疗结果的预测因子
  • 批准号:
    10663903
  • 财政年份:
    2021
  • 资助金额:
    $ 4.82万
  • 项目类别:
Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis
中枢敏化和睡眠障碍作为膝骨关节炎患者治疗结果的预测因素
  • 批准号:
    10306938
  • 财政年份:
    2021
  • 资助金额:
    $ 4.82万
  • 项目类别:
Mentorship of Junior Investigators on HEAL-SKOAP
HEAL-SKOAP 初级研究员的指导
  • 批准号:
    10426755
  • 财政年份:
    2021
  • 资助金额:
    $ 4.82万
  • 项目类别:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
改善膝骨关节炎疼痛患者预后的序贯策略
  • 批准号:
    10352674
  • 财政年份:
    2019
  • 资助金额:
    $ 4.82万
  • 项目类别:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
改善膝骨关节炎疼痛患者预后的序贯策略
  • 批准号:
    10700013
  • 财政年份:
    2019
  • 资助金额:
    $ 4.82万
  • 项目类别:
Increasing Participant Diversity in a 'Sequenced-Strategy to Improve Outcomes in people with Knee Osteoarthritis Pain (SKOAP)
增加“改善膝骨关节炎疼痛患者预后的顺序策略”(SKOAP) 的参与者多样性
  • 批准号:
    10400316
  • 财政年份:
    2019
  • 资助金额:
    $ 4.82万
  • 项目类别:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
改善膝骨关节炎疼痛患者预后的序贯策略
  • 批准号:
    10271400
  • 财政年份:
    2019
  • 资助金额:
    $ 4.82万
  • 项目类别:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
改善膝骨关节炎疼痛患者预后的序贯策略
  • 批准号:
    10917533
  • 财政年份:
    2019
  • 资助金额:
    $ 4.82万
  • 项目类别:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
改善膝骨关节炎疼痛患者预后的序贯策略
  • 批准号:
    10258492
  • 财政年份:
    2019
  • 资助金额:
    $ 4.82万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 4.82万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了